Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection

Acta Tropica

Volumn 123, Issue 3, 2012, Pages 170-177

  Caldas, Sérgio ^a,b   Caldas, Ivo Santana ^a   Diniz, Lívia de Figueiredo ^a   Lima, Wanderson Geraldo de ^a   Oliveira, Riva de Paula ^a   Cecílio, Alzira Batista ^b   Ribeiro, Isabela ^c   Talvani, André ^a   Bahia, Maria Terezinha ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

^c Drugs for Neglected Diseases Initiative   (Switzerland)

Author keywords

CCL2; CCL5; Chemotherapy; D.i.; Experimental model; FBE; Inflammation; Itz; NO; Real time PCR; TNF ; Trypanosoma cruzi

Indexed keywords

DNA; ITRACONAZOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; RANTES;

BLOOD; CHEMOTHERAPY; DISEASE TREATMENT; HEALTH RISK; INFECTIVITY; MUSCLE; PARASITE; PARASITOLOGY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TRYPANOSOMIASIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; CARDITIS; CHAGAS DISEASE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; IMMUNOASSAY; MALE; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITE LOAD; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TISSUE CHARACTERIZATION; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPROTOZOAL AGENTS; BLOOD; CHAGAS DISEASE; CHEMOKINE CCL2; CHEMOKINE CCL5; DISEASE MODELS, ANIMAL; FEMALE; HEART; ITRACONAZOLE; MICE; NITRIC OXIDE; PARASITE LOAD; REAL-TIME POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI;

ANIMALIA; MURINAE; MUS; TRYPANOSOMA CRUZI;

EID: 84863438607     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2012.05.002     Document Type: Article

References (46)

1. Aliberti J.C., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., Silva J.S. Beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infection and Immunity 1999, 67:4819-4826.
2. Bankowski M.J., Anderson S.M. Real-time nucleic acid amplification in clinical microbiology. Clinical Microbiology News 2004, 26:9-15.
3. Benvenuti L.A., Roggerio A., Freitas H.F., Mansur A.J., Fiorelli A., Higuchi M.L. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Annals of Tropical Medicine and Parasitology 2008, 102:481-487.
4. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de Sao Paulo 1962, 4:389-396.
5. Caldas I.S., Talvani A., Caldas S., Carneiro C.M., Lana M., Guedes P.M.M., Bahia M.T. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitology Research 2008, 103:413-421.
6. Chagas C. Nova tripanosomíase humana: estudos sobre a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen. n.sp., agente etiológico de nova entidade mórbida do homem. Memorias do Instituto Oswaldo Cruz 1909, 1:159-218.
7. Cockerill F.R. Application of rapid-cycle real-time polymerase chain reaction for diagnostic testing in the clinical microbiology laboratory. Archives of Pathology and Laboratory Medicine 2003, 127:1112-1120.
8. Coelho P.S., Klein A., Talvani A., Coutinho S.F., Takeuchi O., Akira S., Silva J.S., Canizzaro H., Gazzinelli R.T., Teixeira M.M. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-gamma-primed-macrophages. Journal of Leukocyte Biology 2002, 71:837-844.
9. Cummings K.L., Tarleton R.L. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Molecular and Biochemical Parasitology 2003, 129:53-59.
10. de Freitas V.L., da Silva S.C., Sartori A.M., Bezerra R.C., Westphalen E.V., Molina T.D., Teixeira A.R., Ibrahim K.Y., Shikanai-Yasuda M.A. Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level. PLoS Neglected Tropical Diseases 2011, 5:e1277.
11. Dias J.C. Epidemiology of Chagas disease. Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine 1992, 49-80. ISBT Brasil, São Paulo. S. Wendel, Z. Brener, M.S. Camargo, A. Rassi (Eds.).
12. Dias J.C., Silveira A.C., Schofield C.J. The impact of Chagas disease control in Latin America: a review. Memorias do Instituto Oswaldo Cruz 2002, 97:603-612.
13. Duffy T., Bisio M., Altcheh J., Burgos J.M., Diez M., Levin M.J., Favaloro R.R., Freilij H., Schijman A.G. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Neglected Tropical Diseases 2009, 3:e419.
14. Elias M.C., Vargas N., Tomazi L., Pedroso A., Zingales B., Schenkman S., Briones M.R. Comparative analysis of genomic sequences suggests that Trypanosoma cruzi CL Brener contains two sets of non-intercalated repeats of satellite DNA that correspond to T. cruzi I and T. cruzi II types. Molecular and Biochemical Parasitology 2005, 140:221-227.
15. Filardi L.S., Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987, 81:755-759.
16. Gascon J., Albajar P., Canas E., Flores M., Prat J., Herrera R.N., Lafuente C.A., Luciardi H.L., Moncayo A., Molina L., Munoz J., Puente S., Sanz G., Trevino B., Sergio-Salles X. Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic. Revista Espanola de Cardiologia 2007, 60:285-293.
17. Gonzalez A., Prediger E., Huecas M.E., Nogueira N., Lizardi P.M. Minichromosomal repetitive DNA in Trypanosoma cruzi: its use in a high-sensitivity parasite detection assay. Proceedings of the National Academy of Sciences of the United States of America 1984, 81:3356-3360.
18. Hardison J.L., Wrightsman R.A., Carpenter P.M., Kuziel W.A., Lane T.E., Manning J.E. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infection and Immunity 2006, 74:135-143.
19. Junqueira A.C., Chiari E., Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of north-eastern Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 1996, 90:129-132.
20. Kirchhoff L.V., Votava J.R., Ochs D.E., Moser D.R. Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. Journal of Clinical Microbiology 1996, 34:1171-1175.
21. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Current Opinion in Immunology 2002, 14:129-135.
22. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008.
23. Machado F.S., Souto J.T., Rossi M.A., Esper L., Tanowitz H.B., Aliberti J., Silva J.S. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes and Infection 2008, 10:1558-1566.
24. Marcon G.E., Andrade P.D., de Albuquerque D.M., Wanderley J.S., de Almeida E.A., Guariento M.E., Costa S.C. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagnostic Microbiology and Infectious Disease 2002, 43:39-43.
25. Moreno M., D'avila D.A., Silva M.N., Galvão L.M., Macedo A.M., Chiari E., Gontijo E.D., Zingales B. Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease. Memorias do Instituto Oswaldo Cruz 2010, 105:918-924.
26. Moser D.R., Kirchhoff L.V., Donelson J.E. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. Journal of Clinical Microbiology 1989, 27:1477-1482.
27. Paiva C.N., Figueiredo R.T., Kroll-Palhares K., Silva A.A., Silverio J.C., Gibaldi D., Pyrrho A.S., Benjamim C.F., Lannes-Vieira J., Bozza M.T. CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. Journal of Leukocyte Biology 2009, 86:1239-1246.
28. Pérez-Fuentes R., Guégan J.F., Barnabé C., López-Colombo A., Salgado-Rosas H., Torres-Rasgado E., Briones B., Romero-Díaz M., Ramos-Jiménez J., Sánchez-Guillén M.C. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. International Journal for Parasitology 2003, 33:293-299.
29. Piron M., Fisa R., Casamitjana N., Lopez-Chejade P., Puig L., Verges M., Gascon J., Prat J., Portus M., Sauleda S. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Tropica 2007, 103:195-200.
30. Roggero E., Perez A., Tamae-Kakazu M., Piazzon I., Nepomnaschy I., Wietzerbin J., Serra E., Revelli S., Bottasso O. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clinical and Experimental Immunology 2002, 128:421-428.
31. Saeftel M., Fleischer B., Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infection and Immunity 2001, 69:2252-2259.
32. Sallusto F., Lanzavecchia A., Mackay C.R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunology Today 1998, 19:568-574.
33. Schijman A.G., Vigliano C.A., Viotti R.J., Burgos J.M., Brandariz S., Lococo B.E., Leze M.I., Armenti H.A., Levin M.J. Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic chagas heart disease. American Journal of Tropical Medicine and Hygiene 2004, 70:210-220.
34. Schofield C.J., Jannin J., Salvatella R. The future of Chagas disease control. Trends in Parasitology 2006, 22:583-588.
35. Stegelmann F., Bastian M., Swoboda K., Bhat R., Kiessler V., Krensky A.M., Roellinghoff M., Modlin R.L., Stenger S. Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. Journal of Immunology 2005, 175:7474-7483.
36. Stordeur P., Poulin L.F., Craciun L., Zhou L., Schandené L., de Lavareille A., Goriely S., Goldman M. Cytokine mRNA quantification by real-time PCR. Journal of Immunological Methods 2002, 259:55-64.
37. Talvani A., Coutinho S.F., Barcelos L.S., Teixeira M.M. Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins. Parasitology Research 2009, 104:1141-1148.
38. Talvani A., Ribeiro C.S., Aliberti J.C., Michailowsky V., Santos P.V., Murta S.M., Romanha A.J., Almeida I.C., Farber J., Lannes-Vieira J., Silva J.S., Gazzinelli R.T. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes and Infection 2000, 2:851-866.
39. Talvani A., Teixeira M.M. Inflammation and Chagas disease: some mechanisms and relevance. Advances in Parasitology 2011, 76:171-194.
40. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends in Parasitology 2002, 18:262-265.
41. Toledo M.J., Bahia M.T., Carneiro C.M., martins-filho O.A., Tibayrenc M., Barnabé C., Tafuri W.L., Lana M. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy 2003, 47:223-230.
42. Urbina J.A. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Tropica 2010, 115:55-68.
43. Vespa G.N., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infection and Immunity 1994, 62:5177-5182.
44. Villalta F., Zhang Y., Bibb K.E., Kappes J.C., Lima M.F. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infection and Immunity 1998, 66:4690-4695.
45. World Health Organization (WHO), 2002. Control of Chagas disease. Second Report of the WHO Expert Committee. WHO Technical Report Series. 905, Geneva, 109p.
46. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. Journal of Infectious Diseases 1999, 180:480-486.